Episode 64. New RCT Study: Hydrocortisone Reduces Mortality by 48% in Severe Community Acquired Pneumonia

Roger Seheult, MD of MedCram explores a new RCT study that shows a 48% reduction in mortality in severe community acquired pneumonia when patients receive intravenous hydrocortisone. See all Dr. Seheult's videos at: https://www.medcram.com (This video was recorded on March 26, 2023) Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT: Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred FOLLOW US ON SOCIAL MEDIA: https://www.facebook.com/MedCram https://twitter.com/MedCramVideos https://www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor. #hydrocortisone #pneumonia #RCT